Cargando…
Enhanced antitumor efficacy of cisplatin in combination with HemoHIM in tumor-bearing mice
BACKGROUND: Although cisplatin is one of the most effective chemotherapeutic agents, cisplatin alone does not achieve a satisfactory therapeutic outcome. Also cisplatin accumulation shows toxicity to normal tissues. In this study, we examined the possibility of HemoHIM both to enhance anticancer eff...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2666758/ https://www.ncbi.nlm.nih.gov/pubmed/19292900 http://dx.doi.org/10.1186/1471-2407-9-85 |